Authors' reply to 'RE: A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group'.
Saved in:
| Title: | Authors' reply to 'RE: A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group'. |
|---|---|
| Authors: | Nishina T; Department of Gastrointestinal Medical Oncology, NHO Shikoku Cancer Center, Ehime, Japan., Boku N; Department of Oncology and General Medicine, IMSUT Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan., Kurokawa Y; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan., Sasaki K; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan., Machida R; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan., Yoshikawa T; Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan. |
| Source: | Japanese journal of clinical oncology [Jpn J Clin Oncol] 2025 Jan 08; Vol. 55 (1), pp. 89-90. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
